|
Medical News -
General Medical News - end 2009
|
|
The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 and 141. NICE has put its initial draft guidance on the NICE website, and this is now open for public consultation...
 Read more:
|
